COVID-19 Host Immune Response Pathogenesis (CHIRP) Study

For UCSF Faculty and Staff: Please login via MyAccess to request access to update your Project.

May 24, 2020 - May 24, 2022

Project contact: Sulggi Lee

PI: Sulggi Lee, MD PhD

Funding: N/A grants submitted to NIH x 2; philanthropy

Public Summary

The purpose of our study is to rapidly enroll people who are COVID+ (as well as close contacts exposed to COVID+ people but did not get very ill). It is an intensive study with 5 in-person visits, but we do this so that we can understand the early immune response to fight SARS-CoV-2. Your samples (blood, urine, nasal swab, etc.) will then be distributed to as many researchers here at UCSF and outside of UCSF to help try to find better tests to diagnose COVID, prevent COVID, and treat COVID. After your first phone call interview, we will see you in-person at the study site for 5 visits (1, 2, 4, 8, and 24 weeks after the phone interview). You will compensated $35 for each in-person visit.

Type of Research: Clinical trial

Topics: Antibody, Research Methods, Cell Culture, Sequencing, Screen, Immunofluorescence, Organ, Eye, Skin, Lung, Liver, Kidney, Heart, Cardiovascular, Brain, Applied Research, Immunology, Host Response, Host Factors, Target Population, Research Site, Mental Health, Psychology, Immunity, Co-Morbidities, Clinical Trial, Clinical Presentation of Infection, Biomarkers, Health Disparities, Epidemiology, Transmission, Aerosol, Risk Factors, Incidence, Clinical Outcome, Clinical History, Computational Analysis, Viral Detection, Antibody Detection, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors